ArticleThe Iowa orthopaedic journal2024
Efficacy of Intraoperative Cell Salvage on Perioperative Blood Transfusion in Pelvic and Acetabular Surgery: A Matched Cohort Analysis.
Article in The Iowa orthopaedic journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pelvic fractures often result in traumatic and intraoperative blood loss. Cell salvage (CS) is a tool where autologous blood lost during surgery is collected and recycled with anticoagulation, centrifugation to separate red blood cells, and washing to be reinfused back to the patient. The purpose of this study was to investigate our experience with CS in pelvic and acetabular surgery and its relationship to perioperative transfusion requirements. Methods: After institutional review board approval, adult patients who underwent pelvic ring or acetabular open reduction internal fixation between 01/2014-11/2021 at a tertiary care level-one trauma center were retrospectively reviewed. Peri-operative outcomes including pre-/post-operative hemoglobin and hematocrit, estimated blood loss, use of CS, and perioperative blood transfusions were collected. Pooled two-sample t-tests were used to compare parametric populations while Fischer's exact test or Pearson's Chi squared test were used for nonparametric data. Results: 402 patients were included (85 in the CS group and 317 in the non-CS group). Patients had a higher proportion of acetabular fractures. The use of CS was associated with longer operative time (366 mins vs. 269 mins, p<0.0001), EBL (911 mL vs. 473 mL, p<0.0001), and allogenic transfusion of RBC units intraoperatively (1.75 u vs. 1.28 u, p=0.0442) and postoperatively (1.38 u vs. 0.66 u, p<0.0012). Conclusion: The use of CS was associated with higher total and postoperative allogenic units transfused. Future prospective randomized trials would help to further delineate the risks and benefits of CS utilization in surgical treatment of these fractures.
Indexed as
Identifiers
39811164PMC11726483What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.